Sikkerhed og effekt af Neulasta er ikke blevet vurderet hos patienter, der modtager kemoterapi forbundet med forsinket myelosuppression for eksempel nitrosourea.
The safety and efficacy of Neulasta have not been evaluated in patients receiving chemotherapy associated with delayed myelosuppression e. g., nitrosoureas.